欧罗巴Uomo患者报告结果研究2.0-前列腺癌患者报告结果以支持治疗决策
Lionne D F Venderbos1, Sebastiaan Remmers1, André Deschamps2
1Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
European urology focus
|June 2, 2023
概括
欧洲人类患者报告结果研究2.0 (EUPROMS 2.0) 调查了3571名前列腺癌患者. 治疗影响生活质量,影响尿失禁,性功能,疲劳和失眠.
科学领域:
- 在瘤学瘤学.
- 患者报告的结果
- 医疗保健服务研究 医疗服务研究
背景情况:
- 欧罗巴Uomo患者报告结果研究2.0 (EUPROMS 2.0) 是为了放大前列腺癌 (PCa) 护理中的患者声音而启动的.
- 这项研究解决了对PCa治疗后患者体验的现实数据的需求.
研究的目的:
- 收集PCa患者治疗后身体和精神健康的自我报告数据.
- 为未来的患者提供关于PCa治疗影响的见解.
- 为PCa护理中的共享决策流程提供信息.
主要方法:
- 对PCa患者进行了一项横截面调查 (EUPROMS 2.0).
- 使用了包括EQ-5D-5L,EORTC-QLQ-C30,EPIC-26和SDM-Q-9在内的验证问卷.
- 描述性统计分析了人口统计,临床和患者报告的结果数据.
主要成果:
- 来自30个国家的3571名男性在2021年10月至2022年1月期间完成了调查.
- 积极的PCa治疗对生活质量产生了负面影响,特别是性功能,疲劳和失眠.
- 激进的前列腺切除与较低的尿失禁水平相关,与积极监测相比.
结论:
- EUPROMS 2.0成功收集了大量的患者体验数据,突出了治疗的主要副作用.
- 这些发现强调了解决尿失禁,性功能,疲劳和失眠在PCa生存中的重要性.
- 该研究通过提供可访问的信息来增强医生与患者关系和共享决策,为患者提供权力.
相关概念视频
01:21Cancer Survival Analysis
402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402
01:20Disorders of the Male Reproductive System
481
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
481
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K